Flat Glass Market Size, Share & Forecast | US$ 8.8 Billion by 2032

The global flat glass market is anticipated to grow at an average CAGR of 5.2% from 2022 to 2032, reaching a value of US$ 8.8 billion by that time. The target market will grow from a value of US$ 5 Bn in 2021 to an anticipated US$ 5.3 Bn in 2022. The market for flat glass is expanding as a result of increased demand for building components that are long-lasting, inexpensive, and energy-efficient. During the projected period, a rising change in consumer preference for glass in interior and exterior building structures for aesthetic value will further support the target market’s expansion.

The primary development engine for the flat glass market is the quickly developing building industry. The market for flat glass is expanding as a result of rising spending on infrastructure projects and the construction of environmentally friendly green buildings, both of which are projected to help reduce carbon emissions into the atmosphere.

Flat glass sales will probably increase internationally due to the growing need for renewable energy around the world. This is true because solar panels, e-glass buildings, and photovoltaic modules all frequently use flat glass. Thus, as the demand for renewable energy increases, so does that for flat glass. Traditional materials like bricks, stone, and wood are being increasingly replaced by this substance. Insulated flat glass is furthermore transparent and recyclable, enhancing both environmental protection and occupant comfort.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-367

Another factor that propels the market growth is the booming automobile industry. Tempered glass is increasingly utilized by automotive manufacturers owing to its shatterproof properties, which can help avoid severe injuries and potential life threats in the course of an accident. Other aspects, like the application of nanotechnology to make lightweight glazing glass and solar control panels, along with growing urbanization and increasing disposable incomes, are fueling to the flat glass market during the forecast period.

“A surge in infrastructure spending on the development of green and eco-friendly buildings will supplement the global growth of the flat glass market over the forecast period,” says an FMI analyst.  

Key Takeaways:

  • Expanding construction and infrastructure sector drives the market growth.
  • Fluctuating raw material prices may hamper the market growth.
  • Expanding residential construction sector will propel the target market in the United States.
  • The Asia Pacific region is expected to dominate the target market during 2022-2032.
  • Infrastructural development in the Asia Pacific region will fuel the flat glass market.

Competitive Landscape 

Asahi Glass, Nippon Sheet Glass, Guardian Industries, and Saint-Gobain among others are some of the major players in the flat glass market profiled in the full version of the report.

Key market players are focusing on forming strategic alliances to amplify their market share. These enterprises are employing tactics like partnerships and collaborations to strengthen their market positions.

Ask Your Queries @ https://www.futuremarketinsights.com/ask-question/rep-gb-367

More Insights into Flat Glass Market Report

In its latest report, FMI offers an unbiased analysis of the global flat glass market, providing historical data from 2015 to 2020 and forecast statistics for 2022 to 2032. To understand the global market potential, growth, and scope, the market is segmented on the basis of glass type (toughened flat glass, laminated flat glass, coated flat glass, extra clear flat glass, mirrored flat glass, patterned flat glass, annealed flat glass), application (flat glass for silicones, flat glass for agriculture chemicals, flat glass for pharmaceuticals, flat glass for chemical intermediates, flat glass for personal care, flat glass for other applications), and region.

According to the latest FMI reports, based on region, the Asia Pacific will offer signification growth opportunities to the flat glass market during 2022-2032. This region is anticipated to account for a major share of the global flat glass market owing to the fact that a vast share of flat glass consumption comes from ASEAN countries, China, Japan, and many others. Infrastructural growth in this region will also foster growth for the target market during this period of observation.

In North America, the flat glass market will expand at a high growth rate due to the rising construction of privately owned housing in the United States. Thus, North America and Asia Pacific are two of the regions likely to offer various lucrative opportunities for the flat glass market during the forecast period.

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com

 

 

Infusion Pumps Market is expected to reach US$ 6.6 Billion by 2030 | FMI

[295 Pages Report] FMI’s recent report on infusion pumps projects the market to surge at a CAGR of 5.4% from 2020-2030. Growth is attributed to increasing diabetic population across prominent regions. As per World Health Organization’s projections, there were 422 million diabetic people as of 2014, with a 5% increase in premature mortality.

Consequently, there has also been an increase in associated co-morbidities such as strokes, heart attacks, kidney failure and visual impairment. As a result, infusion pump usage has upticked in order to provide the appropriate medication and nutritional input.

To facilitate efficient drug delivery, manufacturers have incorporated various technological advancements in recent years. Additionally, the advent of wearable and smart infusion pumps is further fueling the market’s revenue prospects.

To remain ahead of your competitors, request for a sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-859

Infusion Pumps Market Outlook:

Data Points Market Insights
Market Value 2022 USD 4.4 Bn
Market Value 2030 USD 6.6 Bn
CAGR 2022-2030 5.0%
Key Players The key players are CareFusion Corporation, ICU Medical, Inc., Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Terumo Corporation, Medtronic Plc, Smiths Medical, MOOG Inc., and Johnson & Johnson Services, Inc.
Share of Top 5 Countries 46.8%

Global Infusion Pumps Market- Key Takeaways

  • Rising prevalence of cancer to push forward oncology-grade infusion pumps usage in the coming years
  • Ambulatory pumps are poised to hold major sway in the wake of swift drug and nutrient delivery
  • Europe to pivot global infusion pumps market growth, capturing over 1/3rd of the revenue pie
  • Global infusion pumps market is likely to surpass US$ 6 Bn by 2030-end
  • Favorable business reimbursement policies are expected to bolster infusion pumps demand in coming years

COVID-19 Impact Analysis

The COVID-19 pandemic is anticipated to have a moderate impact on the global infusion pumps market. In the initial months of the pandemic’s onset, a slump in the demand-supply equation was observed. This was in response to the imposition of lockdowns and social distancing protocols. Eventually, a resurgence was recorded.

In recent months, regulatory authorities such as the U.S Food and Drug Administration (FDA) issued emergency use authorization to increase the availability of infusion pumps and related accessories. Infusion pumps have been pivotal in administering vital medicines and parenteral nutrition to patients admitted for chronic ailments.

As hospitals reach a saturation point, governments are providing flexibility to infusion pump manufacturers to address supply shortages by permitting them to resume operations. This is slated to sustain the infusion pumps market demand in the short-term forecast.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-859

Global Infusion Pumps Market- Competitive Intelligence

Prominent players 

  • Fresenius Kabi AG,
  • Terumo Corporation,
  • Medtronic Plc,
  • Baxter International Plc.,
  • Smith Medical,
  • MOOG Inc.,
  • Johnson & Johnson Services Inc.,
  • ICU Medical Inc. and
  • Becton Dickinson & Company among others.

Product launches, expansions, collaborations and other inorganic strategies are being pursued by the aforementioned players. In 2019, Terumo Corporation announced the launch of its TERUFUSION Infusion Pump Type LM Series which utilize smart cutting-edge IT solutions to deliver optimal management and prevents inadvertent excess infusion of drugs into the patient.

In 2010, Hospira Inc. partnered with Smith Medical to market and promote various infusion pumps. The companies collaborated in order to co-promote Hospira’s Symbiq and Plum A+ general infusion pumps along with its Hospira MedNet safety software. The venture also promoted Smith Medical’s Medfusion syringe pumps with the PharmGuard Medication Safety Software.

More Insights on the Infusion Pumps Market Report

A recent market study published by FMI on the ophthalmic lasers market includes the global industry analysis of 2015-2019 & opportunity assessment for 2020-2030, and delivers a comprehensive assessment of the most important market dynamics. The report incorporates an unbiased analysis of the following segments: product type (syringe pumps, ambulatory pumps, volumetric pumps, implantable pumps, insulin pumps, enteral pumps, PCA pumps and pump accessories), application (chemotherapy/oncology, pediatrics/neonatology, analgesia, gastroenterology, hematology and diabetes), end-user (hospitals, ambulatory surgical centers, homecare, clinics and others) and region (North America, Latin America, Europe, MEA, East Asia, South Asia and Oceania).

Infusion Pumps Market – Key Segment

Product Type

  • Syringe Pumps
  • Ambulatory Pumps
  • Volumetric Pumps (Peristaltic and Cassette/Piston)
  • Implantable Pumps
  • Insulin Pumps
  • Enteral Pumps
  • PCA Pumps
  • Pump Accessories

Application

  • Chemotherapy/Oncology
  • Pediatrics/Neonatology
  • Analgesia
  • Gastroenterology
  • Hematology
  • Diabetes

For in-depth insights, Download a PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-859

End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Homecare
  • Clinics
  • Others

Region

  • North America
  • Latin America
  • Europe
  • Middle East & Africa (MEA)
  • East Asia
  • South Asia
  • Oceania

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports : https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Foley Catheter Market Application, Trends, Growth, Opportunities and Worldwide Forecast to 2030

Foley catheters  Market Size also known as urinary catheters, are flexible tubes that are passed through the urethra and bladder to facilitate easy drainage of urine. They are considered essential in the urology sector, aiding patients with bladder dysfunctions to drain urine into urine bags, and reducing urology-related complications. The prevalence of urological diseases – such as urinary retention, benign prostate hyperplasia (BPH), bladder obstruction, urinary incontinence, and prostate cancer – has witnessed a significant uptick in the recent past. According to the statistics of the Centers for Disease Control and Prevention (CDC), nearly 15-25% of hospitalized patients receive a urinary catheter annually. As the number of hospital admissions continues to rise year-on-year, there is a persistent need for foley catheters in hospitals, which are projected to remain a crucial end-use segment.

Likewise, the growing burden of urinary retention, a chronic condition in which individuals cannot voluntarily urinate, is propelling demand for foley catheters to facilitate easy drainage of urine. As per the estimates of the American Academy of Family Physicians (AAFP), approximately 4.5 to 6.8 per 1,000 men in the US suffer from urinary retention. As the incidence of disorders continues to grow across the world, the demand for foley catheters is poised to remain high for the years to come.

Along similar lines, the high prevalence of urinary incontinence, a condition that causes the urine to leak involuntarily, is projected to bestow remunerative opportunities to players in the foley catheters market. The severity of urinary incontinence rises with age, with men above 70 being the most affected. The expanding base of the geriatric population will continue to necessitate the usage of foley catheters.

COVID-19 Impact on Foley Catheters Market

COVID-19 is expected to create slight fluctuations in the growth trajectory of the foley catheters market. There has been a notable shift in priorities of healthcare institutions, with treatment for COVID-19 patients being the utmost priority across the world. Hospitals in severely affected nations such as the US and India have deprioritized non-essential hospitalizations, leading to a downfall in the demand for foley catheters. With urology not being the most concerning healthcare issue currently, the sales of numerous urology care devices, including foley catheters are likely to witness a decline across hospitals. However, the demand for foley catheters in long-term care facilities is poised to remain unhinged through the pandemic, and will continue to drive the sales of these devices.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-7769

Having analyzed and scrutinized all the aforementioned facets in its new market study, Future Market Insights (FMI) projects that the global foley catheters market will grow in value at a CAGR of nearly 5% between 2020 and 2030. Some of the key takeaways from the report include:

  • The global foley catheters market is expected to surge past valuation of US$ 2.2 Bn by the end of 2030.
  • By product type, 2-way foley catheters are poised to remain the most sought-out variants, owing to their wide availability and simple installation, and will hold more than half of the overall market value.
  • Among materials, latex-based foley catheters are expected to gain an edge over their counterpart, silicon-based foley catheters, backed by their ability to reduce urethral irritation.
  • Based on indication, urinary incontinence is expected to remain the largest segment, on the back of high incidence among geriatric population.
  • North America will remain at the forefront of the regional landscape ascribed to high expenditure on medical aids coupled with new product approvals.
  • Asia Pacific and Europe will continue to bestow remunerative opportunities to market players.

 “With catheter-acquired infections being a major challenge to the adoption of foley catheters, manufacturers are focusing on developing products with materials and coatings that aid in reducing accumulation of bacteria, thus restraining the possibility of catheter-acquired infections among patients” remarks FMI analyst.

Get In Touch With Our Team For 30% Flat Discount: https://www.futuremarketinsights.com/ask-question/rep-gb-7769

Who is Winning?

Major players in the market are focusing on developing advanced catheters that reduce the likelihood of the patient developing catheter-associated infections. To achieve the same, they are using novel materials and coatings, and are seeking approvals to commercialize their devices. On these lines,

  • C.R Bard is using silver-ion and antimicrobial coatings in the production of foley catheters to eliminate the risk of catheter-associated infections when used for long periods.
  • B. Braun Melsungen AG continues to develop its catheter product line named Actreen® catheters, designed specifically for urinary retention, and are coated with lubricants to make it comfortable and hygienic to use.
  • In 2019, Safe Medical Design Inc., procured FDA approval to commercialize its new catheter designed to reduce to urethral trauma.

FMI’s report includes profiles of some of the most prominent names in the market including Teleflex Incorporated, Cardinal Health, C.R Bard, B. Braun Melsungen AG, Coloplast A/S, Medtronic plc, Flume, ConvaTec Group, VOTG Medical, Sterimed Group, Ribbel International Limited, Angiplast Private Limited, Mais India Medical Devices Private Limited, and JK Medirise.

Ask for Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-7769

Key Segments

Type:

  • 2 Way
  • 3 Way
  • 4 Way

Material:

Latex Foley Catheter

  • Hydrogel-Coated Latex Foley Catheters
  • Silicon-Coated Latex Foley Catheter
  • Silver-Coated Latex Foley Catheters
  • “PTFE (polytetrafluoroethylene) (teflon)
  • Coated Latex Foley Catheters

Silicon Foley Catheter

  • Hydrogel-Coated Silicone Foley Catheters
  • Pure Silicone Foley Catheters
  • Silver Coated Silicon Foley Catheters
  • Others

Indication:

  •  Urinary Incontinence
  •  Urethral Stricture
  •  Chronic Obstruction
  •  Neurogenic Bladder
  •  Enlarged Prostate Gland/BPH
  •  Prostate Cancer
  •  Others

End-user:

  • Hospitals
  • Long Term Care Facilities
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

 

 

Branded Generics Market Analysis, Recent Trends and Regional Growth Forecast by 2031

[280 Pages Report] ESOMAR-certified consulting firm Future Market Insights (FMI) in its latest report forecasts that the global branded generics market will register healthy growth at a CAGR of 5.8% between 2021 and 2031.

The swift growth of branded generics market can be attributed to the growing number of patent expiry of branded or blockbuster drugs along with increasing prevalence of chronic diseases. Rising demand for cheap medical treatments is positively impacting the demand in the market.

Branded generics are pharmaceutical drugs that have been re-released with a different brand name. They are used to treat various diseases such as diabetes, hypertension, back pain and others. These drugs occupy small but lucrative subset of the entire generic market

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1260

Since branded generics are free from patenting, companies are investing handsome amounts on this drug category. The market is set to reach a valuation of around 283.2 Bn in 2021, with top players in tier-1 accounting for 20%-25% market share.

The entry of new players, simple market authorization procedures, greater profit margin and off-invoice discounts will expand branded generics market during the forecast period.

As per the FMI’s analysis, despite the slight setback due to the pandemic, the global branded generics market registered year-on-year (Y-o-Y) growth at 4.9% CAGR during 2020-2021.

“Rising demand for branded generics across both developing and developed economies along with high penetration of pharmaceutical industry will offer lucrative growth opportunities for the branded generics manufacturers during the forecast period” says the FMI analyst.

Key Takeaways from FMI’s Branded Generics Market Study

  • China and India are spearheading the growth of Asia Pacific market spurred by the increasing adoption of branded generics by large-scale pharmacy chains in the emerging economies
  • The U.S. will lead the North America’s branded generics market, registering a growth at 3.83% CAGR during the forecast period.
  • The market in India is expected to offer lucrative growth opportunities to branded generics manufacturers backed the expansion of pharmaceutical industry
  • In terms of therapeutic application, cardiovascular diseases and diabetes are expected to account for considerable market share
  • Oral solid dose pharmaceutical formulation continues to be highly preferred among patients. The oral segment accounts for over 55% share of the global branded generics market.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1260

Competitive Landscape

Teva, Abbott Laboratories, Novartis, Mylan, Pfizer are some prominent players operating in the branded generics market cumulatively hold around 20-25% market share.

Key players operating in branded generic market are focusing on expanding their business in emerging markets. They are adopting various organic and inorganic growth strategies such as mergers and acquisitions, advanced product development and collaborations to gain a competitive edge in the market.

  • In October 2020, Glenmark Pharmaceuticals, introduces NINDANIB (Nintedanib) for the treatment of pulmonary fibrosis in India. Glenmark has been amongst the first to launch the branded generic version at an affordable cost for the treatment of pulmonary fibrosis in India.

More Valuable Insights on Branded Generics Market

In its latest report, FMI provides an incisive coverage on the global branded generics market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031.The study provides compelling insights on branded generics market on the basis of therapeutic application (oncology, cardiovascular diseases, diabetes, neurology, gastro intestinal diseases, dermatology diseases, analgesic and others), drug class (alkylating agents, anti-metabolites, hormones, anti-hypertensives, lipid lowering drugs, anti-depressants, anti-psychotics, anti-epileptics and others ), formulation type (oral, parenteral, topical, others) and distribution channel (hospital pharmacies, retail pharmacies, online pharmacies, drug stores) across seven major regions.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-1260

Branded Generics Market by Category Therapeutic Application:

  • Oncology
  • Cardiovascular Diseases
  • Diabetes
  • Neurology
  • Gastrointestinal Diseases
  • Dermatology Diseases
  • Analgesics and Anti-inflammatory
  • Others

Drug Class:

  • Alkylating Agents
  • Antimetabolites
  • Hormones
  • Anti-Hypertensive
  • Lipid Lowering Drugs
  • Anti-Depressants
  • Anti-Psychotics
  • Anti-Epileptics
  • Others

Formulation Type:

  • Oral
  • Parenteral
  • Topical
  • Others

Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Dental Sutures Market Value to Grow by Almost US$ 892.9 Mn from 2022 – 2032 FMI

Dental sutures are medical devices that aid in the healing process of the teeth. Despite the huge influx of wound closure procedures, suturing remains to be one of the most used in a range of medical disciplines, including density.

Sutures are still being used by dentists across the globe to fix surgical flaps and close wounds in order to aid recovery. As per Future Market Insights, the global dental sutures market was valued around US$ 453.8 Mn in 2021 and is predicted to exhibit a CAGR of close to 6.5% over the forecast period (2022-2032).

The major cause of early childhood caries (ECC) in children has been identified as frequent sugar consumption, insufficient tooth brushing, poor access to dental care, and insufficient fluoride. With rising prevalence of oral cavities among children, the demand for dental sutures is expected to rise during the forecast period.

According to Centre for Disease Control and Prevention (CDC) data for 2019, more than half of children of age from 6 to 8 years have a cavity in any of their baby teeth and more than half of adolescents of age from 12 to 19 years suffer from a cavity in any of their permanent teeth.

With advancements in suturing materials, post-surgical problems and infections have decreased considerably. This is expected to increase the application of advanced suturing systems, boosting the dental sutures market.

Moreover, rising geriatric population is also driving the demand for dental sutures. Due to tooth loss in the elderly, which necessitates dental sutures for dental implants and other dental operations, the worldwide dental sutures market is likely to gain traction over the forecast period.

Get Sample of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14626

Key Takeaways from Market Study

  • By product, absorbable suture products are expected to hold over 61.7% market value share by the end of 2032.
  • Synthetic materials are leading with over 63.3% of the market share in 2021 and are expected to hold a market value share of around 63.1% by 2032.
  • By end-user, dental clinics hold the highest market share value of 66.6% in 2021, expanding at a CAGR of 6.5% in the forecast period.
  • North America is the leading region with a value share of 34.4% in 2021, owing to the increasing incidences of oral cancer cases and increasing dental procedures in the region.

“With increasing advancements in upgrading suturing materials, and surging number of product approvals and launches, the global dental suture market will witness robust growth over the forecast period,” says an analyst of Future Market Insights.

Request Customization of the report @ https://www.futuremarketinsights.com/customization-available/rep-gb-14626

Market Competition

Key players operating in the global dental suture market include Henry Schein, Inc., Dentsply Sirona, and B.Braun. Business expansion and new product launches are the key strategies adopted by the leading manufacturers to enhance their reach in the market and compete with other competitors during the coming years.

Key Market Segments Covered in Dental Sutures Industry Research

By Product:

  • Absorbable
  • Non-Absorbable

By Material:

  • Natural
  • Synthetic

By End-User:

  • Hospital
  • Dental Clinics
  • Ambulatory Surgical Centres

By Technique:

  • Interrupted Simple Sutures
  • Continuous Simple Sutures
  • Matteress Sutures
  • Crisscross Sutures

Get Discount on the Report @ https://www.futuremarketinsights.com/request-discount/rep-gb-14626

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Supply-Side

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Product USPs

    4.2. Recent product approval and launches

    4.3. Key Promotional Strategies by Market Players

    4.4. Product Adoption/ Usage Analysis by region

    4.5. Regulatory Scenario

    4.6. Reimbursement Scenario

    4.7. PESTEL Analysis

    4.8. Porter’s Analysis

TOC Continue…

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports : https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Teleradiology Market to Register a CAGR of 15.3% by 2032 – Exclusive Report by FMI

As per a study by ESOMAR-certified consulting firm Future Market Insights (FMI), The teleradiology market is projected to register a CAGR of 15.3% during the forecast period, up from US$ 7.3 Bn in 2021. Favored by the increasing number of medical imaging procedures such as computed tomography (CT) scans and X-ray scans, the sales of teleradiology are likely to surge at a vigorous 15.3% CAGR during the assessment period.

Rising prevalence of diseases such as cancer, arthritis, cellulitis, and osteomyelitis are facilitating the market growth. According to the National Institute of Cancer, around 1898,160 new incidences of cancer are estimated to be diagnosed in 2021, causing approximately 608,570 deaths in the U.S.

As teleradiology enables the transfer of radiological images to qualified radiologists for providing effective treatments, it plays a life-saving function for patients. Thus, with the increasing number of cancer cases and lack of availability of skilled radiologists in sub-urban and rural areas, the demand for teleradiology systems is likely to increase over the coming year.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-1747

The coronavirus outbreak has favored the teleradiology market by increasing demand for medical imaging procedures across the globe. As the use of teleradiology systems avoids in-person contacts for the exchange of hard imaging result copies, these systems are increasingly being adopted by hospitals, medical institutes, and clinics for sharing study observations and details information gathered, thereby, driving teleradiology sales.

Key Takeaways from FMI’s Teleradiology Market Study

Sales of teleradiology systems are expected to rise at 9.10% between 2020 and 2021.

  • The U.S. is estimated to dominate the North America teleradiology market owing to the presence of leading market players in the country.
  • China is likely to emerge as the prominent market in Asia Pacific due to the high prevalence of chronic diseases such as cancer and arthritis.
  • Based on modality, CT scans are anticipated to lead the segment, on the back of rising digitalization and technological advancements in the segment.
  • Owing to the surging demand for diagnostic imaging procedures due to the lack of qualified radiologists, ambulatory imaging centres (AICs) are expected to account for substantial revenue share.

Competitive Landscape

Teleradiology Solutions, Argus Radiology, SRL Diagnostics, USARAD Holdings, Inc., Vital Radiology Services, and Telemedicine Clinic are the leading players operating in the teleradiology market as profiled by FMI.

The teleradiology market is highly fragmented owing to the presence of large number of market players. Leading player emphasizing on launching the new products and expanding their product portfolio to gain competitive edge over other player. Besides, this some of the players are adopting strategies such as strategic collaboration, merger, acquisition, and partnership with other industry players to strength their market footprint.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-1747

Why Future Market Insights?

  • Comprehensive analysis on evolving purchase pattern across different geographies
    • Detailed insights of market segments and sub-segments for historical as well as forecast period
    • A competitive analysis of prominent players and emerging players in the keyword market
    • Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports : https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Sennosides Market is projected to reach a valuation of US$ 345.0 Mn by 2022, is likely to grow at 4.3% CAGR between 2022 and 2032 | FMI

[376 Pages Report] Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Sennosides Market. The study features insights on the current growth dynamics and the major revenue reforms prevailing in the market as of 2019 along with the key takeaways over the forecast period 2020 to 2030.

The team of analysts at Future Business Insights are focussing on research and market study to produce different Sennosides Market forecasts and predictions at both national and international levels. They have considered several leads of information pertaining to the industry like market figures and merger estimations to assess and produce reliable and informative insights on the Sennosides Market.

To remain ‘ahead’ of your competitors, Ask a Question >> https://www.futuremarketinsights.com/ask-question/rep-gb-12887

Key Players

The writer will create content on the general strategies of market players. And then will write the key players in the market are: NOW Health Group Inc. (Now Foods), Changsha Vigorous-Tech, Vital Laboratories, Health and Herbs, Alchem International, Shaanxi Hongda Phytochemistry, Nutra Green Biotechnology Co. Ltd, Elixir Natural Labs, Shaanxi Jintai Biological Engineering, SAB Herbals & Nutraceuticals, Santen, Apex International and Others

Segmentation

The report provides insights on the important highlights and current trends prevailing in the market. This helps the readers to gain a deeper understanding and form an unbiased opinion on the market. Numerous segmentations have been provided for this market based on:

Based on the Type :

  • Sennosides B
  • Sennosides A

Based on the Product Form :

  • Tablet (chewable, sugar-coated)
  • Liquid (syrup, extract)
  • Powder
  • Others

Based on the End-user :

  • Pharmaceuticals Industry
  • Food Industry
  • Research laboratories
  • Cosmetics
  • Others

Based on the Application  :

  • Cathartics & Laxatives
  • Nutraceuticals
  • Surgery
  • Others

Get Access to Research Methodology Prepared by Experts >> https://www.futuremarketinsights.com/askus/rep-gb-12887

Product Segmentation

The investigation offers a top to bottom evaluation of different clients’ journeys pertinent to the market and its segments. The study endeavours to assess the current and future development possibilities, undiscovered roads, factors that shapes their income potential in the global market by breaking it into di such as its types, applications, and region-wise assessment.

By Regional Analysis Covered

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (India, China ASEAN, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

Full in-depth analysis of the parent market

The analysts at FMI are dedicated to provide insights after extensive research and study. The study also includes estimations, projections and evaluation of the market dynamics.

Important changes in market dynamics

The report has been created after detailed and exhaustive studies by the analysts at FMI taking several factors into consideration like monetary, ecological, social, mechanical, and political status of a particular demography. They study the key data to assess the revenue and production of manufacturers across various regions. The report also covers an in-depth analysis of the key changes in market dynamics in the recent past and the near future.

Segmentation details of the market

  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets

Queries Solved

  • What is the size of the overall Sennosides Market in the Healthcare Industry and its segments?
  • What are the key segments and sub-segments in the market?
  • What are the key drivers, restraints, opportunities, and challenges of the Sennosides Market in the Healthcare Industry, and how they are expected to impact the market?
  • What are the attractive investment opportunities within the Sennosides Market in the Healthcare Industry?
  • What is the Sennosides Market in the Healthcare Industry size at the regional and country-level?
  • What are the key market players focusing on?
  • What are the strategies for growth adopted by the key players in Sennosides Market in the Healthcare Industry?
  • What are the recent trends in Sennosides Market in the Healthcare Industry? (M&A, partnerships, new product developments, expansions)?
  • What are the challenges to the Sennosides Market in the growth of the Healthcare Industry?
  • What are the key market trends impacting the growth of the Sennosides Market in the Healthcare Industry?

To receive extensive list of important regions, ask for TOC here >> https://www.futuremarketinsights.com/toc/rep-gb-12887

Table of Content

  • Executive Summary
  • Market Overview
  • Key Success Factors
  • Global Sennosides Market – Pricing Analysis
  • Market Background

Reasons to Buy the report

  • We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
  • Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.
  • The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape

Liquid Biopsy Market Forecast : Global liquid biopsy market demand is anticipated to be valued at US$ 1,146 Million in 2022, forecast a CAGR of 13.49% to be valued at US$ 4,126 Million from 2022 to 2032.

Digital Patient Monitoring Systems Market Value : The global Digital Patient Monitoring Systems market is estimated at US$ 96.4 Bn in 2022 and is projected to reach a valuation of US$ 470 Bn by 2032, expanding at a CAGR of 17.2% through the forecast period of 2022-2032.

Medical Drones Market Sales : The medical drones market is anticipated to flourish in the worldwide market at a strong CAGR of 24.3% during the forecast period, reaching a revenue of US$ 280.6 Mn in 2022

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Pressure Infusion Bags Market is projected to reach US$ 494.5 Million by 2029 | FMI

[317 Pages Report] A new market research report by Future Market Insights on the pressure infusion bags market includes global industry analysis 2014 – 2021 and opportunity assessment 2022 – 2029. The report investigates the pressure infusion bags market and provides critical insights for the forecast period of 2022 -2029.

As per the findings of the report, the global pressure infusion bags market is projected to experience significant growth over the forecast period due to multiple driving factors such as increasing emergency and transfusion cases and development of healthcare infrastructure across geographies.

The global pressure infusion bags market was valued at ~US$ 300 Mn in 2021, and is expected to increase at a CAGR of ~6.5% during the forecast period of 2022-2029. This growth is majorly driven by the increasing use of pressure infusion bags for rapid infusion of blood and drugs, in order to protect the end organ damage during traumatic conditions.

The overall progress of the healthcare sector and infrastructure in MEA and Asia-Pacific are likely to unfold lucrative opportunities for market players operating in the pressure infusion bags market. In addition, manufacturers are expected to primarily focus on developing cost-effective and user-friendly bags in the coming years. 

South Asia Continues to Hold Lucrative Opportunities

Regions such as North America and East Asia are expected to hold prominent market shares in terms of value. However, the South Asia market is expected to project lucrative growth in the global pressure infusion bags market over the forecast period of 2022-2029.

This growth is propelled by the rapid growth and development of healthcare infrastructure, especially trauma care units, intensive care units and ambulatory surgical centers in countries of South Asia that include India and ASEAN countries. The economic condition of these countries have been developing positively, thereby creating newer growth opportunities for the market players.

Macroeconomic factors such as growing population, increasing immunosuppressed patient population, and increase in the number of players along with strong distribution network and rapid development in the healthcare infrastructure have attracted the attention of manufactures to establish a firm collaboration with local distributors in South Asia.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2243

Hospitals and Outpatient Facilities Remain Key End Users for Pressure Infusion Bags

The global market of pressure infusion bags has been segmented on the basis of different types of pressure infusion bags products, their multiple applications, their volume capacity, their material, their targeted indications and regions such as North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East and Africa.

  • By type, the disposable type of pressure infusion bags segment is expected to hold prominent value shares of the global pressure infusion bags market. This has majorly resulted to avoid and minimizing chances of cross contamination during fluid infusion and ensures the patient safety
  • On the basis of application, the blood and drug infusion segment is expected to consume majority share of the global pressure infusion bags market value. Invasive Pressure monitoring procedures is the second application which account the remaining market share.

Pressure Infusion Bags Market: Vendor Insights

The report highlights some of the prominent market players, who have established themselves as leaders in the global pressure infusion bags market. Some of the examples of key players in the global pressure infusion bags market are VBM Medizintechnik GmbH, ERKA, Smiths Medical (Smiths Group plc.), Friedrich Bosch GmbH & Co. KG, Biegler GmbH, SARSTEDT AG & Co. KG. Vyaire Medical Inc., Spengler SAS, Armstrong Medical, SunMed and Statcorp Medical

Pressure Infusion Bags Market by CategoryBy Product: 

  • Reusable Pressure Infusion Bags
  • Disposable Pressure Infusion Bags

By Material:

  • Nylon
  • Polyurethane
  • Latex
  • Others

By Capacity:

  • 500cc
  • 1000cc
  • 3000cc
  • Above 3000cc

 By Application:

  • Blood & Drug Infusion
  • Invasive Pressure Monitoring Procedure

By Indications:

  • Trauma-Induced Haemorrhage
  • Obstetric Haemorrhage
  • Coagulopathy during cardiopulmonary bypass

By End User:

  • Hospitals
  • Out-patient facilities
  • Clinics
  • Long-term care centers

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2243

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 8-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Real-time Bioprocess Raman Analyzer Market is expected to reach a valuation of around US$ 50.8 Mn as of 2032

[202 Pages Report] The global demand for real-time bioprocess raman analyzer was valued at 17.8 Mn in 2021 and is expected to grow at a CAGR of 10.1% from 2022 to 2032. According to the study, market sales are expected to reach a valuation of around US$ 50.8 Mn by 2032. In 2021, the instrument segment accounted for more than 90% of the market value share.

Market Outlook:

Data Points Market Insights
Real-Time Bioprocess Raman Analyzer Market Value 2021 US$ 17.8 Mn
Market Value 2022 US$ 19.4 Mn
Market Value 2032 US$ 50.8 Mn
CAGR 2022-2032 10.1%
Market Share of Top 5 Countries, 2021 75.8%

The benefits of Raman spectroscopy as data processing in real-time has made significant contribution as a diagnostic and control tool for pharmaceutical production and bioprocessing, with scientific and financial benefits demonstrated throughout the product life cycle. This has led to the growth of real-time bioprocess Raman analyzers market. Future Market Insights (FMI) in a new study has forecast real-time bioprocess raman analyzers market to expected to exhibit a CAGR of 14.6% during the forecast period (2020-2030).

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6912

Leading market players are focusing on mergers and acquisitions with biopharmaceutical industries and contract manufacturing organizations (CMO). This would help them expand their global footprint. Among end-use segments, contract manufacturing organizations are leading the market, which is then followed by biopharmaceutical companies. Contract manufacturing organizations are anticipated to grow at a CAGR of around 15.9% over the forecast period.

Increasing biopharmaceutical production and reduced cost benefits are expected to fuel Real-time bioprocess Raman Analyzers market growth in the coming decade. The digital transformation for data processing in real-time rising investments into R&D and initiative by regulatory bodies to improvise the development and approval process of biopharmaceutical products and fast track the process is has led to the real-time bioprocess Raman Analyzers market growth.

However, there are few challenges in the real-time bioprocess raman analyzers market like the availability of a skilled workforce which is acting as a restraint in the growth of the market. Lack of information about the product leading to lesser adoption of the Real-time bioprocess Raman Analyzers is acting as a restraint for the market growth.

Key Takeaways from Real-time bioprocess Raman Analyzers Market Study

  • The global Real-time bioprocess Raman Analyzers market is estimated to surpass US$ 8.7 Mn by 2021
  • The U,S, will emerge as dominant market in North America, accounting for over 95% of the overall sales
  • The U.K. will exhibit growth at a positive pace. According to FMI, it is expected to register nearly 20% Y-o-Y growth in 2021
  • Both Germany and France are expected to emerge as attractive markets for realtime bioprocess raman analyzer in Europe
  • Within East Asia, China will account for higher share of proceeds gained by the market

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6912

“Increasing research and development activities are expected to boost the growth for Real-time bioprocess Raman Analyzers Market. On the other hand, there is a rising demand for quality healthcare and pharmaceuticals. This has been creating significant growth opportunities for key players” says the FMI Analyst  

Want more insights?

Future Market Insights (FMI) brings the comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global Real-time bioprocess Raman Analyzers market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the Real-time bioprocess Raman Analyzers market on basis of a component type (Raman Analysers, Raman Probes, and Software), applications (Lab to Process Analysis and Bioprocess Analysis), and end-users (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Research Organizations) across four major regions.

Who is Winning?

The global market is set to broaden its scope in the forecast period, driven by the increasing adoption rate of real-time and automated solutions during bioprocessing, advancements in technology, and reduced cost in manufacturing of biopharmaceuticals. However, lack of a skilled workforce and inadequate information about the benefits has constrained the sales of Real-time bioprocess Raman Analyzers.

Some of the key players operating in the market are Kaiser Optical Systems (Endress+Hauser), Resolution Spectra Systems Inc. (Merck KGaA), Tornado Spectral Systems, and Sartorius AG. Leading companies are consolidating their positions through mergers, acquisitions, and collaborations.

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/6912

Real-time bioprocess Raman Analyzers Market by Category Component Type

  • Instruments
    • Raman Analyzers
    • Raman Probes
  • Software

Application

  • Lab to Process Analysis
  • Bioprocess Analysis

End User

  • Biopharmaceutical Companies
  • Contract Manufacturing Organizations
  • Research Organizations

Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Tip Location Devices Market to reach US$ 70.2 Million by 2030 | FMI

The global tip location devices market is likely to surpass USD 35 million in revenues by 2020-end, according to a latest report by Future Market Insights (FMI). The ESOMAR-certified firm has an optimistic outlook on the long-term prospects of tip location devices market, with its latest report forecasting a 6.4% CAGR through 2030.

Tip location devices are being commercialized as a solution to incorrect positioning of catheters. Using tip locator devices does reduce incidences of this incorrect positioning by 10-16% as they make use of micro sensors to gauge the catheter’s position. This, in turn, reduces the cost of catheterization as the conventional technique of X-Rays is not employed over here. This precision followed by cost-effectiveness are likely to drive the tip location devices market in the forecast period.

Moreover, the players have been an active part of global conferences with respect to showcasing the product portfolio. These measures are expected to increase the visibility of the players as a brand.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-880

For instance – Teleflex Incorporated, in Sep 2019, participated at the conference conducted by Cardiovascular and Interventional Radiological Society of Europe by presenting its Peripheral Intervention Product Portfolio. The conference was held in Barcelona.

Key Takeaways from Tip Location Devices Marker Study

  • Tip location system anticipated to witness a CAGR of 5% between 2020 and 2030
  • ECG with magnetic tracking accounted for more than 60% of market share in terms of revenue in 2019.
  • North America to account for more than 50% of market share in 2020 and the trend is expected to continue in the forecast period.

Competitive Intelligence

The global market is set to widen its scope in the forecast period, stimulated by rising number PICC procedures globally and adoption of tip confirmatory systems for during catheter insertion. The key market players covered by FMI include C.R. Bard, Inc., Teleflex Incorporated, AngioDynamics Inc., Vygon S.A., CORPAK MedSystems. Coming up with easy-to-use and advanced tip location devices is one of the objectives of these players.

For instance – Teleflex’s “Arrow VPS Rhythm Device with TipTracker Technology” does need any calibration, expedites patient therapy (with elimination of X-Ray or Fluoroscopy), and simplifies PICC insertion.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-880

On the similar lines, AngioDynamics has tabled next generation of Peripheral Atherectomy Technology. Acquiring Auryon has facilitated this state-of-the art technology.

CORTRAK* 2 ENTERAL ACCESS SYSTEM (EAS) is an electromagnetic stylet from Avanos that gives real-time location information regarding placement of the tip of the tube. One could get immediate feedback due to on-screen visualization. This eliminates use of X-Ray.

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com